Results
Nectar Lifesciences Q2 Net Loss ₹129 Crore
Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY27, reporting a net loss from continuing operations of ₹1,138 lakhs for H1.
Company shifted focus to real estate
